ConductScience.org, home

Paper7397697

Radiolabeling of antibodies.

Eckelman WC and 2 others. Cancer Res, 1980. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Radiolabeling of antibodies. Papers, record 7397697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7397697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiolabeling of antibodies.
PubMed
Journal
Cancer Res
PubMed
Year
1980
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eckelman WCW C
2Paik CHC H
3Reba RCR C

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Isotope LabelingMajor topic
Chelating Agents
Chemical Phenomena
Chemistry
Humans
Indium
Iodine Radioisotopes
Neoplasms
Radiation Dosage
Substrate Specificity
Technetium

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
36314010Immuno-PET: Design options and clinical proof-of-concept.Front Med (Lausanne)2022https://conductscience.org/library/papers/36314010PubMed
33632875A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis.Mol Cancer Ther2021https://conductscience.org/library/papers/33632875PubMed
32579891Near-infrared fluorescence imaging in immunotherapy.Adv Drug Deliv Rev2020https://conductscience.org/library/papers/32579891PubMed
23928799Optimization of microfluidic PET tracer synthesis with Cerenkov imaging.Analyst2013https://conductscience.org/library/papers/23928799PubMed
20187791Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.Cancer Biother Radiopharm2010https://conductscience.org/library/papers/20187791PubMed
8814727Applicability of short-lived radiometallic nuclide for high sensitivity two-site "sandwich" immunoradiometric assay: human growth hormone assay.Ann Nucl Med1996https://conductscience.org/library/papers/8814727PubMed
6409238Improved tumour localisation using indium-111 labelled antibodies.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6409238PubMed
6352009Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6352009PubMed
6169388Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6169388PubMed
4076233Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.Eur J Nucl Med1985https://conductscience.org/library/papers/4076233PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7397697

GET https://conductscience.org/api/papers/v1/7397697/authors